News

Basel HealthTech fund successfully closed

The venture capital firm MTIP has announced the successful closing of its FUND II. It is one of the first funds to invest in innovative European HealthTech firms in the growth phase.

Christoph Kausch, Managing Partner at MTIP.
Christoph Kausch, Managing Partner at MTIP. Image provided by MTIP

MTIP has completed the fundraising phase for its second fund. As the Basel-based private equity firm announced on December 7, it raised a total of 250 million US dollars in capital commitments under its MTIP Fund II instead of the original target of 225 million US dollars.

The “dark green”, sustainability-focused fund is one of the first of its kind to specialize in the HealthTech sector. It invests in digital health companies and digitally-connected medical technology firms with the aim of supporting international expansion plans. “We are excited to announce the successful closing of our second fund and continue our mission to build the HealthTech leaders of tomorrow”, explains Christoph Kausch, Managing Partner at MTIP, in the press release.

New and existing investors in the fund included institutional investors, pension funds, family offices, hospitals, foundations and the health insurance firm Sanitas, further details of which can be found in the press release. Andreas Schönenberger, CEO of Sanitas, praised MTIP’s “unique expertise in HealthTech” that allows it to foster innovation “in this under-served private equity sector”.

MTIP writes further in the press release that it has already made successful investments in five companies as part of its MTIP Fund II: Oviva, Trialbee, Koa Health, Intelligencia and Mediktor.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

En savoir plus sur le sujet
Partager

Programme officiel